Perennial Investment Advisors’s Tema Oncology ETF CANC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$791K Buy
19,182
+11,800
+160% +$447K 0.05% 251
2026
Q1
$271K Buy
+7,382
New +$269K 0.02% 419

Other funds holding CANC

Perennial Investment Advisors's CANC Position: Q2 2026 in Review

Perennial Investment Advisors increased its Tema Oncology ETF (CANC) stake by 160% in Q2 2026, buying an estimated $447K and bringing the position to 19,182 shares worth $791K. The position accounts for 0.05% of the portfolio, ranked #251.

Perennial Investment Advisors first reported a position in CANC in Q1 2026 and has held it in 2 quarters since. 15 funds tracked by Wall St. Rank hold CANC as of Q2 2026.

  • Perennial Investment Advisors held 19,182 shares of Tema Oncology ETF worth $791K as of Q2 2026.
  • Perennial Investment Advisors bought 11,800 Tema Oncology ETF shares in Q2 2026, an estimated $447K.
  • Tema Oncology ETF made up 0.05% of Perennial Investment Advisors's portfolio in Q2 2026, its #251 holding.
  • Perennial Investment Advisors first reported a position in Tema Oncology ETF in Q1 2026 and has held it in 2 quarters since.
  • 15 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q2 2026.

Based on Perennial Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.